Tech Company Financing Transactions
Engimmune Therapeutics Funding Round
On 5/3/2022, Engimmune Therapeutics raised $15.5 million in Seed financing from Novo Ventures, Pureos Bioventures and private investors.
Browse more venture capital transactions:
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs